NCT03607695

Brief Summary

The aging Veteran population, together with high exposure to Agent Orange or other herbicides during military service, has made diseases such as Parkinson's disease (PD), currently affecting more than 80,000 Veterans, a major health issue in the Veterans' health system. Mobility and cognitive limitations are a common problem in PD and are associated with significant disability, increased fall risk, reduced quality of life, and increased caregiver burden. While less is known about its benefit on cognition, physical therapy has proven to be an effective treatment to mitigate mobility limitations, though the response to rehabilitation interventions is highly variable. The proposed research will inform the investigators' understanding of the impact of certain genetic profiles associated with learning impairments on motor and cognitive benefits in response to gait rehabilitation, and will provide an important foundation for more personalized and improved gait rehabilitation programs for different subgroups of PD patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2018

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

July 24, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 31, 2018

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2020

Completed
1.3 years until next milestone

Results Posted

Study results publicly available

October 27, 2021

Completed
Last Updated

October 27, 2021

Status Verified

September 1, 2021

Enrollment Period

2.4 years

First QC Date

July 24, 2018

Results QC Date

August 11, 2021

Last Update Submit

September 28, 2021

Conditions

Keywords

gaitexercisecognitiongenetics

Outcome Measures

Primary Outcomes (2)

  • Gait Speed (m/s)

    The investigators will use the APDM Movement Monitoring system to assess gait speed (m/s) during straight-line walking as a measure of gait function.

    measured at baseline, 2 weeks, 10 weeks and 16 weeks

  • Montreal Cognitive Assessment Score

    The investigators will use the Montreal Cognitive Assessment (MoCA; score range=0-30, with 30 indicating better cognitive function) as a reflection of global cognitive function

    measured at baseline and at 10 weeks

Study Arms (1)

Gait training

EXPERIMENTAL

1 hour walking exercise on a treadmill

Other: Gait training

Interventions

Walking on a treadmill and receiving audio cues to improve gait

Gait training

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may not qualify if:

  • Have a Hoehn \& Yahr score of 3
  • Have the ability to walk 400 m without physical assistance from a device or another person
  • Do not have other health conditions (e.g., orthopedic, cardiopulmonary) that impact the ability to safely participate in a moderately intense gait training program
  • The investigators will exclude those patients presenting clinical diagnosis of dementia.
  • The investigators will exclude those patients presenting conditions (cardiac, renal, or metabolic) that would pose a risk to their health by exercising.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

VA Puget Sound Health Care System Seattle Division, Seattle, WA

Seattle, Washington, 98108, United States

Location

MeSH Terms

Conditions

Parkinson DiseaseMotor Activity

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative DiseasesBehavior

Limitations and Caveats

This trial was impacted by local and institutional restrictions on research implemented during the start of the COVID-19 pandemic. Restrictions on research activities impacted recruitment and impacted data collection for some participants.

Results Point of Contact

Title
Valerie E. Kelly, PT, PhD
Organization
University of Washington

Study Officials

  • Ignacio Fernandez-Mata

    VA Puget Sound Health Care System Seattle Division, Seattle, WA

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Model Details: The intervention is a 10-week gait, treadmill-training program. The sessions are 1 hour long, twice a week.
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 24, 2018

First Posted

July 31, 2018

Study Start

February 1, 2018

Primary Completion

June 30, 2020

Study Completion

June 30, 2020

Last Updated

October 27, 2021

Results First Posted

October 27, 2021

Record last verified: 2021-09

Data Sharing

IPD Sharing
Will not share

We will not make individual participant data available.

Locations